XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
1.090
-0.010 (-0.91%)
At close: Dec 20, 2024, 4:00 PM
1.060
-0.030 (-2.75%)
After-hours: Dec 20, 2024, 4:03 PM EST
XORTX Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -0.74 | -2.16 | -7.72 | -1.58 | -1.28 | -0.63 | |
Depreciation & Amortization | 0.12 | 0.14 | 0.06 | 0.01 | 0.02 | 0.02 | |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.06 | - | |
Stock-Based Compensation | 0.14 | 0.12 | 0.49 | 0.46 | 0.29 | 0.03 | |
Other Operating Activities | -3.59 | -3.66 | -3.26 | -2.61 | -0.18 | 0.04 | |
Change in Accounts Receivable | 0.06 | 0.02 | -0.04 | -0.03 | - | 0.01 | |
Change in Accounts Payable | -0.23 | -1.19 | 0.89 | -0.26 | 0.41 | 0.35 | |
Change in Other Net Operating Assets | 0.15 | 0.14 | 0.62 | -0.79 | -0.04 | -0.07 | |
Operating Cash Flow | -4.09 | -6.58 | -8.96 | -4.8 | -0.73 | -0.25 | |
Capital Expenditures | -0 | -0 | -0.02 | - | - | - | |
Sale (Purchase) of Intangibles | -0.04 | -0.04 | -0.03 | -0.03 | -0.01 | -0.01 | |
Investing Cash Flow | -0.04 | -0.05 | -0.05 | -0.03 | -0.01 | -0.01 | |
Long-Term Debt Repaid | - | -0.07 | -0.02 | - | - | - | |
Net Debt Issued (Repaid) | -0.06 | -0.07 | -0.02 | - | - | - | |
Issuance of Common Stock | 2.02 | 0 | 5 | 20.07 | 0.9 | 0.07 | |
Other Financing Activities | -0.59 | -0.3 | -0.27 | -0.7 | -0.04 | -0.01 | |
Financing Cash Flow | 1.36 | -0.36 | 4.71 | 19.37 | 0.86 | 0.06 | |
Foreign Exchange Rate Adjustments | 0.01 | 0 | -0.14 | 0.2 | - | - | |
Net Cash Flow | -2.77 | -6.99 | -4.44 | 14.74 | 0.11 | -0.2 | |
Free Cash Flow | -4.09 | -6.59 | -8.98 | -4.8 | -0.73 | -0.25 | |
Free Cash Flow Per Share | -1.60 | -3.32 | -6.07 | -4.39 | -0.98 | -0.42 | |
Levered Free Cash Flow | -1.71 | -4.2 | -3.8 | -0.83 | -1.74 | 0.03 | |
Unlevered Free Cash Flow | -1.71 | -4.2 | -3.8 | -0.82 | -1.73 | 0.05 | |
Change in Net Working Capital | 0.15 | 1.32 | -1.47 | -0.18 | 1.34 | -0.31 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.